Drug Recalls in Canada
Medication recalls and safety alerts, pulled directly from Health Canada's Recalls and Safety Alerts database — the same source your pharmacy checks.
Last synced Nov 19, 2026, 9:00 a.m.
1057 results
PegLyte Powder
PegLyte Powder: Affected lots may contain foreign matter
Low health risk
Taro-Candesartan tablets
TARO-CANDESARTAN: affected lots may contain Esomeprazole 20mg capsules
Moderate health risk
SECARIS NASAL GEL
SECARIS NASAL GEL: Affected lot may contain foreign matter
Moderate health risk
Unauthorized peptides (injectable and capsule format)
Health Canada warns about unauthorized peptides, including contaminated injectable peptides sold by Sage & Summit Wellness Co. in Ottawa, ON
PDP-DIPHENHYDRAMINE
PDP-DIPHENHYDRAMINE 25 MG and 50 MG CAPSULES: Out-of-specification (Impurity)
Moderate health risk
Unauthorized injectable peptide and non-peptide drugs
Health Canada warns about contaminated unauthorized injectable peptides and non-peptide drugs
ANTICOAGULANT SODIUM CITRATE SOLUTION, USP
ANTICOAGULANT SODIUM CITRATE SOLUTION, USP 4g/100mL and Potential Bag Leaks
Cyclophosphamide for Injection USP
Cyclophosphamide for Injection USP: Presence of particulate matter
Highest health risk
Femyso Mifepristone 200mg / Misoprostol 200 mcg tablet
Femyso: Affected lot may contain two green Mifepristone cartons or two pink Misoprostol cartons instead of one of each.
Moderate health risk
Dantrium Intravenous (Dantrolene sodium for injection)
Dantrium Intravenous (Dantrolene sodium for injection): Presence of particulate matter
Highest health risk
Aleve
Aleve 200 mg caplets: Recalled from wholesalers (Distribution Error)
Low health risk
Claritin Allergy Tablets
Claritin Allergy Tablets 10 mg: Recalled from wholesalers (Distribution Error)
Low health risk
PMS-Carvedilol
PMS-Carvedilol 25 mg Tablets: Out-of-specification (Impurity)
Moderate health risk
PMS-FAMPRIDINE
PMS-FAMPRIDINE 10 mg Tablet: Affected lot may contain foreign material particles.
Moderate health risk
Carvedilol
Carvedilol 25 mg Tablets: Out-of-specification (Impurity)
Moderate health risk
CARVEDILOL
Carvedilol 25 mg Tablets: Out-of-specification (Impurity)
Moderate health risk
PDP-DIPHENHYDRAMINE
PDP-DIPHENHYDRAMINE 25 MG CAPSULE: Out-of-specification (Impurity)
Moderate health risk
Apo-Semaglutide Injection
Apo-Semaglutide Injection : Incorrect dose display
Moderate health risk
Novo-Gesic Forte 500 mg tablets (acetaminophen)
Generic acetaminophen by Teva recalled because it may contain foreign material
Highest health risk
JAMP Temozolomide
JAMP Temozolomide: Out-of-Specification (Assay)
Moderate health risk
Apo-Semaglutide
Apo-Semaglutide Injection : Incorrect dose display
Moderate health risk
Semaglutide Injection
Semaglutide Injection : Out-of-Specification (Impurity)
Moderate health risk
Twins Herbal Idakole and Twins Herbal Pelorie
Twins Herbal Products: Undeclared prescription drug (sildenafil)
Highest health risk
BONKY Injection, 1 mcg/mL Calcitriol
Importation of South Korean-Authorized BONKY Injection, 1 mcg/mL Calcitriol, due to the Current Shortage of Canadian-Authorized Calcitriol Injection USP, 1 mcg/mL
CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE
CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE: The level of the degradation product Benzaldehyde may be out of specification in the affected lots.
Low health risk
Various unauthorized health products, including prescription drugs
Unauthorized drugs seized from Rabais 4Saisons Inc. in Montreal, QC, may pose serious health risks
Lactated Ringer's Injection USP
Lactated Ringer's Injection USP: Presence of Particulate Matter
Highest health risk
Teva-Pregabalin 150 mg capsules
Two lots of Teva-Pregabalin 150 mg capsules recalled due to cross-contamination with the drug sertraline
Highest health risk
Various unauthorized—including counterfeit—injectable health products
Unauthorized injectable health products sold online and seized from Dyosa Beauty & Wellness Lounge in Hamilton, ON, may pose serious health risks
pms-IRBESARTAN 150 mg Tablet
pms-IRBESARTAN: Affected lot may contain pms-IRBESARTAN/HCTZ 150/12.5 mg tablets.
Moderate health risk
Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice. See our guides for what to do if your medication is recalled.